News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Arseus NV Enters US with $12.5 Million Gallipot Inc. Buy, Eyes More M&A
May 10, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AMSTERDAM, May 10 (Reuters ) - Belgian medical equipment and services company Arseus NV (RCUS.BR) said on Monday it would buy U.S.-based pharmaceutical supplies company Gallipot Inc. for about $12.5 million in cash, its first step outside of Europe.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
·
2 min read
·
Heather McKenzie
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
September 2, 2025
·
1 min read
·
Annalee Armstrong
Podcast
Lilly’s Obesity Pill Heads to the FDA, AbbVie Bets on Psychedelics, HHS Unveils More Change
August 27, 2025
·
1 min read
·
Jef Akst
China
Pharma Spent More Than $48B in China in H1, Eclipsing Total 2024 Haul
August 27, 2025
·
2 min read
·
Annalee Armstrong